Holger Franz
Overview
Explore the profile of Holger Franz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
313
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Valassi E, Castinetti F, Ferriere A, Tsagarakis S, Feelders R, Netea-Maier R, et al.
Endocr Relat Cancer
. 2022 Oct;
29(12):681-691.
PMID: 36197784
Corticotroph tumor progression after bilateral adrenalectomy/Nelson's syndrome (CTP-BADX/NS) is a severe complication of bilateral adrenalectomy (BADX). The aim of our study was to investigate the prevalence, presentation and outcome of...
2.
Valassi E, Tabarin A, Brue T, Feelders R, Reincke M, Netea-Maier R, et al.
Eur J Endocrinol
. 2019 Sep;
181(5):461-472.
PMID: 31480014
Objective: Patients with Cushing's syndrome (CS) have increased mortality. The aim of this study was to evaluate the causes and time of death in a large cohort of patients with...
3.
Baum R, Kulkarni H, Singh A, Kaemmerer D, Mueller D, Prasad V, et al.
Oncotarget
. 2018 Apr;
9(24):16932-16950.
PMID: 29682195
Introduction: Peptide receptor radionuclide therapy (PRRT) of patients with somatostatin receptor expressing neuroendocrine neoplasms has shown promising results in clinical trials and a recently published phase III study. Methods: In...
4.
Valassi E, Feelders R, Maiter D, Chanson P, Yaneva M, Reincke M, et al.
Clin Endocrinol (Oxf)
. 2018 Mar;
88(6):787-798.
PMID: 29574994
Objective: Hypercortisolism in Cushing's syndrome (CS) is associated with impaired health-related quality of life (HRQoL), which may persist despite remission. We used the data entered into the European Registry on...
5.
Valassi E, Franz H, Brue T, Feelders R, Netea-Maier R, Tsagarakis S, et al.
Eur J Endocrinol
. 2018 Feb;
178(4):399-409.
PMID: 29440375
Background: Surgery is the definitive treatment of Cushing's syndrome (CS) but medications may also be used as a first-line therapy. Whether preoperative medical treatment (PMT) affects postoperative outcome remains controversial....
6.
Valassi E, Franz H, Brue T, Feelders R, Netea-Maier R, Tsagarakis S, et al.
Eur J Endocrinol
. 2017 Apr;
176(5):613-624.
PMID: 28377460
Objective: To evaluate which tests are performed to diagnose hypercortisolism in patients included in the European Registry on Cushing's syndrome (ERCUSYN), and to examine if their use differs from the...
7.
Schofl C, Franz H, Grussendorf M, Honegger J, Jaursch-Hancke C, Mayr B, et al.
Eur J Endocrinol
. 2012 Oct;
168(1):39-47.
PMID: 23087126
Background: Acromegaly is a rare disease with significant morbidity and increased mortality. Epidemiological data about therapeutic outcome under 'real life' conditions are scarce. Objective: To describe biochemical long-term outcome of...
8.
Valassi E, Santos A, Yaneva M, Toth M, Strasburger C, Chanson P, et al.
Eur J Endocrinol
. 2011 Jul;
165(3):383-92.
PMID: 21715416
Objective: The European Registry on Cushing's syndrome (ERCUSYN) is designed to collect prospective and follow-up data at EU level on Cushing's syndrome (CS). Design And Methods: Baseline data on 481...